Effectiveness and safety of cenobamate after conversion to monotherapy or dual therapy in real‐world clinical practice

This study highlights the real-world effectiveness and safety of cenobamate, either as monotherapy (after conversion from polytherapy) or in dual therapy, in patients with drug-resistant epilepsy. Cenobamate allows for a significant treatment simplification, resulting in fewer treatment-related adverse events without compromising seizure reduction.